Banys-Paluchowski, Malgorzata http://orcid.org/0000-0002-2374-9482
Witzel, Isabell
Riethdorf, Sabine
Pantel, Klaus
Rack, Brigitte
Janni, Wolfgang
Fasching, Peter A.
Aktas, Bahriye
Kasimir-Bauer, Sabine
Hartkopf, Andreas
Solomayer, Erich-Franz
Fehm, Tanja
Müller, Volkmar
Funding for this research was provided by:
Roche Pharma AG
Adnagen AG
Oncogene Science
Article History
Received: 3 July 2018
Accepted: 9 July 2018
First Online: 12 July 2018
Compliance with Ethical Standards
:
: Wolfgang Janni received a research grant from Roche. Bahriye Aktas has served as a consultant/advisor for Roche, Pfizer and Novartis. Klaus Pantel has served as a consultant/advisor for Agena Bioscience. Sabine Kasimir-Bauer has served as a consultant/advisor for Qiagen. Peter A. Fasching has served as a consultant/advisor for Amgen, Novartis, Roche, Pfizer, Teva and Puma Celgene and received a research grant from Novartis. Brigitte Rack has received honoraria or research grants from Novartis, Roche, Pfizer, Janssen Diagnostics, Astra Zeneca, Novartis, Lilly, Chugai and Sanofi. Malgorzata Banys-Paluchowski, Isabell Witzel, Sabine Riethdorf, Andreas Hartkopf, Erich-Franz Solomayer, Tanja Fehm and Volkmar Müller declare that they have no conflicts of interest.
: All procedures performed in this study were in accordance with the ethical standard of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the local ethical committees of participation institutions.
: Informed consent was obtained from all individual participants included in the study.